Biodexa Pharmaceuticals (BDRX) Financial Services Fees (2014 - 2015)
Biodexa Pharmaceuticals (BDRX) reported Financial Services Fees of $151749.1 for Q4 2015, up 356.08% on a YoY basis from $33272.5 in Q4 2014, and up 356.08% sequentially from $33272.5 in Q4 2014.
Biodexa Pharmaceuticals (BDRX) Financial Services Fees (2014 - 2015) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 2 years of Financial Services Fees data on file, last reported at $151749.1 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 151,749.05 |
| Dec 31, 2014 | 33,272.47 |